{"id":526413,"date":"2021-08-11T06:03:14","date_gmt":"2021-08-11T10:03:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/"},"modified":"2021-08-11T06:03:14","modified_gmt":"2021-08-11T10:03:14","slug":"haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/","title":{"rendered":"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website"},"content":{"rendered":"<div class=\"xn-newslines\">\n<h2 class=\"xn-hedline\">Financial release accessible online<\/h2>\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">BOSTON<\/span>, <span class=\"xn-chron\">Aug. 11, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2022, which ended <span class=\"xn-chron\">July 3, 2021<\/span>, are available on its Investor Relations website. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg\" title=\"\" alt=\"\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at <span class=\"xn-chron\">8:00 a.m. ET<\/span> on <span class=\"xn-chron\">August 11, 2021<\/span>. The conference call and webcast can be accessed with the following information:<\/p>\n<ul type=\"disc\">\n<li>U.S. \/ <span class=\"xn-location\">Canada<\/span> toll free (877) 848-8880; International (716) 335-9512 <\/li>\n<li>Conference ID required for access: 1674067 <\/li>\n<li>A live webcast of the call can be accessed on Haemonetics&#8217; Investor Relations website\u00a0or via the following link:\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3255269-1&amp;h=2795009986&amp;u=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fi5w7z4hk&amp;a=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fi5w7z4hk\" rel=\"nofollow noopener\">https:\/\/edge.media-server.com\/mmc\/p\/i5w7z4hk<\/a><\/li>\n<\/ul>\n<p>In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.\u00a0\u00a0<\/p>\n<p>Direct link to 1<i>Q FY22 Earnings Release<\/i>: <br \/><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3255269-1&amp;h=3809914987&amp;u=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2Fae3b0356-e98b-45b5-95da-300a335114d7&amp;a=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2Fae3b0356-e98b-45b5-95da-300a335114d7\" rel=\"nofollow noopener\">https:\/\/haemonetics.gcs-web.com\/static-files\/ae3b0356-e98b-45b5-95da-300a335114d7<\/a><\/p>\n<p>Direct link to 1<i>Q FY22 Analytical Tables and Supplemental Information:<\/i><br \/><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3255269-1&amp;h=2843552690&amp;u=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2F7aef5a76-0b37-40ea-91ce-d6b0592279ea&amp;a=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2F7aef5a76-0b37-40ea-91ce-d6b0592279ea\" rel=\"nofollow noopener\">https:\/\/haemonetics.gcs-web.com\/static-files\/7aef5a76-0b37-40ea-91ce-d6b0592279ea<\/a><\/p>\n<p>A replay of the conference call and webcast will be available for one year beginning on <span class=\"xn-chron\">August 11, 2021<\/span> at <span class=\"xn-chron\">11:00 a.m. ET<\/span> using the conference call webcast link provided in this press release.<\/p>\n<p>\n        <b>About Haemonetics<br \/><\/b>Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3255269-1&amp;h=3442455369&amp;u=http%3A%2F%2Fwww.haemonetics.com%2F&amp;a=www.haemonetics.com\" rel=\"nofollow noopener\">www.haemonetics.com<\/a>.<\/p>\n<div>\n<table id=\"convertedTable5e4a\" cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Investor Contact\u00a0<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Media Contact<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Olga Guyette, Director-Investor Relations<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Josh Gitelson, Director-Global Communications<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">(781) 356-9763<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">(781) 356-9776<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:olga.guyette@haemonetics.com\" class=\"prnews_a\" rel=\"nofollow noopener\">olga.guyette@haemonetics.com<\/a>\u00a0\u00a0<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:josh.gitelson@haemonetics.com\" class=\"prnews_a\" rel=\"nofollow noopener\">josh.gitelson@haemonetics.com<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE70826&amp;sd=2021-08-11\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website-301352522.html\">https:\/\/www.prnewswire.com\/news-releases\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website-301352522.html<\/a><\/p>\n<p>SOURCE  Haemonetics Corporation<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NE70826&amp;Transmission_Id=202108110600PR_NEWS_USPR_____NE70826&amp;DateId=20210811\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Financial release accessible online PR Newswire BOSTON, Aug. 11, 2021 \/PRNewswire\/ &#8212;\u00a0Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2022, which ended July 3, 2021, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 11, 2021. The conference call and webcast can be accessed with the following information: U.S. \/ Canada toll free (877) 848-8880; International (716) 335-9512 Conference ID required for access: 1674067 A live webcast of the call can be accessed on Haemonetics&#8217; Investor Relations website\u00a0or via the following link:\u00a0https:\/\/edge.media-server.com\/mmc\/p\/i5w7z4hk In addition, the Company has posted to its &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-526413","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Financial release accessible online PR Newswire BOSTON, Aug. 11, 2021 \/PRNewswire\/ &#8212;\u00a0Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2022, which ended July 3, 2021, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 11, 2021. The conference call and webcast can be accessed with the following information: U.S. \/ Canada toll free (877) 848-8880; International (716) 335-9512 Conference ID required for access: 1674067 A live webcast of the call can be accessed on Haemonetics&#8217; Investor Relations website\u00a0or via the following link:\u00a0https:\/\/edge.media-server.com\/mmc\/p\/i5w7z4hk In addition, the Company has posted to its &hellip; Continue reading &quot;Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-11T10:03:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website\",\"datePublished\":\"2021-08-11T10:03:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/\"},\"wordCount\":342,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/\",\"name\":\"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"datePublished\":\"2021-08-11T10:03:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/","og_locale":"en_US","og_type":"article","og_title":"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website - Market Newsdesk","og_description":"Financial release accessible online PR Newswire BOSTON, Aug. 11, 2021 \/PRNewswire\/ &#8212;\u00a0Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2022, which ended July 3, 2021, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 11, 2021. The conference call and webcast can be accessed with the following information: U.S. \/ Canada toll free (877) 848-8880; International (716) 335-9512 Conference ID required for access: 1674067 A live webcast of the call can be accessed on Haemonetics&#8217; Investor Relations website\u00a0or via the following link:\u00a0https:\/\/edge.media-server.com\/mmc\/p\/i5w7z4hk In addition, the Company has posted to its &hellip; Continue reading \"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-11T10:03:14+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website","datePublished":"2021-08-11T10:03:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/"},"wordCount":342,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/","name":"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","datePublished":"2021-08-11T10:03:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/526413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=526413"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/526413\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=526413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=526413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=526413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}